These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2804340)

  • 1. Disease-free survival after autologous bone marrow transplantation in patients with acute myelogenous leukemia.
    Körbling M; Hunstein W; Fliedner TM; Cayeux S; Dörken B; Fehrentz D; Haas R; Ho AD; Keilholz U; Knauf W
    Blood; 1989 Nov; 74(6):1898-904. PubMed ID: 2804340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous bone marrow transplantation (ABMT) in acute myelogenous leukaemia--Heidelberg experience.
    Pai VR; Korbling M
    J Assoc Physicians India; 1990 Apr; 38(4):275-6. PubMed ID: 2202710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bone marrow autotransplantation in acute myeloblastic leukemia in its first complete remission. The clinical results in 41 patients].
    Tomás JF; Gómez-García de Soria V; Pinilla I; Lamana M; Figuera A; Arranz R; Cámara R; Fernández-Villalta MJ; Alegre A; Fernández-Rañada JM
    Med Clin (Barc); 1997 Feb; 108(6):201-6. PubMed ID: 9102484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Ringdén O; Labopin M; Tura S; Arcese W; Iriondo A; Zittoun R; Sierra J; Gorin NC
    Br J Haematol; 1996 Jun; 93(3):637-45. PubMed ID: 8652385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous bone marrow transplantation in late first complete remission improves outcome in acute myelogenous leukemia.
    Miggiano MC; Gherlinzoni F; Rosti G; Bandini G; Visani G; Fiacchini M; Ricci P; Testoni N; Motta MR; Geromin A; Rizzi S; Belardinelli A; Mangianti S; Manfroi S; Tura S
    Leukemia; 1996 Mar; 10(3):402-9. PubMed ID: 8642854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
    Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
    Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo chemopurging of autologous bone marrow with 4-hydroperoxycyclophosphamide to eliminate occult leukemic cells. Laboratory and clinical observations.
    Yeager AM; Rowley SD; Kaizer H; Santos GW
    Am J Pediatr Hematol Oncol; 1990; 12(3):245-56. PubMed ID: 2240470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved outcome for high-risk acute myeloid leukemia patients using autologous bone marrow transplantation and monoclonal antibody-purged bone marrow.
    Selvaggi KJ; Wilson JW; Mills LE; Cornwell GG; Hurd D; Dodge W; Gingrich R; Martin SE; McMillan R; Miller W
    Blood; 1994 Mar; 83(6):1698-705. PubMed ID: 8123862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous bone marrow transplantation for haematological malignancies--experiences of the centre of Zagreb.
    Nemet D; Labar B; Bogdanic V; Skodlar J; Petrovecki M; Mrsic M; Maravic N; Sneller V; Radman I; Kovacevic-Metelko J
    Wien Med Wochenschr; 1995; 145(2-3):61-4. PubMed ID: 7762256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference in kinetics of hematopoietic reconstitution between ALL and ANLL after autologous bone marrow transplantation with marrow treated in vitro with mafosfamide (ASTA Z 7557).
    Douay L; Laporte JP; Mary JY; Lopez M; Lemonnier MP; Stachowiak J; Benitez O; Deloux J; Najman A; Salmon C
    Bone Marrow Transplant; 1987 Jun; 2(1):33-43. PubMed ID: 3332155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome in acute myelogenous leukemia autografted with mafosfamide-purged marrow in a single institution: adverse events and incidence of secondary myelodysplasia.
    Abdallah A; Egerer G; Weber-Nordt RM; Körbling M; Haas R; Ho AD
    Bone Marrow Transplant; 2002 Jul; 30(1):15-22. PubMed ID: 12105772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous bone marrow transplantation for acute myeloid leukemia using monoclonal antibody-purged bone marrow.
    Ball ED; Mills LE; Cornwell GG; Davis BH; Coughlin CT; Howell AL; Stukel TA; Dain BJ; McMillan R; Spruce W
    Blood; 1990 Mar; 75(5):1199-206. PubMed ID: 2306522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One hundred twenty-five adult patients with primary acute leukemia autografted with marrow purged by mafosfamide: a 10-year single institution experience.
    Laporte JP; Douay L; Lopez M; Labopin M; Jouet JP; Lesage S; Stachowiak J; Fouillard L; Isnard F; Noel-Walter MP
    Blood; 1994 Dec; 84(11):3810-8. PubMed ID: 7949137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of curative effect of autologous peripheral blood stem cell transplantation versus bone marrow transplantation for acute leukemia].
    Zhang YZ; Zhang BL; Yao SQ; Liu HC; Lou FD; Gao CJ; Han XP; Wu XX; Zhao Y; Wang QS; Jing Y; Zhang M; Jin HJ; Shi ZJ; Da WM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Feb; 11(1):81-5. PubMed ID: 12667296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome assessment of age group-specific (+/- 50 years) post-remission consolidation with high-dose cytarabine or bone marrow autograft for adult acute myelogenous leukemia.
    Bassan R; Raimondi R; Lerede T; D'emilio A; Buelli M; Borleri G; Personeni A; Bellavita P; Rodeghiero F; Barbui T
    Haematologica; 1998 Jul; 83(7):627-35. PubMed ID: 9718868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological-mediated purging with mafosfamide in acute and chronic myeloid leukemias. The Italian Study Group.
    Rizzoli V; Mangoni L
    Prog Clin Biol Res; 1990; 333():21-36; discussion 37-8. PubMed ID: 2308982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous marrow transplantation for patients with acute myeloid leukemia in untreated first relapse or in second complete remission.
    Petersen FB; Lynch MH; Clift RA; Appelbaum FR; Sanders JE; Bensinger WI; Benyunes MC; Doney K; Fefer A; Martin P
    J Clin Oncol; 1993 Jul; 11(7):1353-60. PubMed ID: 8315433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous bone marrow transplantation in acute myeloid leukemia: the University of Minnesota experience.
    Dusenbery KE; Steinbuch M; McGlave PB; Ramsay NK; Blazar BR; Neglia JP; Litz C; Kersey JH; Woods WG
    Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):335-43. PubMed ID: 8892457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous transplantation of a bone marrow graft manipulated by chemoseparation to eliminate residual tumor cells.
    Körbling M; Dörken B; Tischbirek K; Zipperle G; Ho AD; Fliedner TM; Hunstein W
    Blut; 1983 Feb; 46(2):89-93. PubMed ID: 6336961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous bone marrow transplantation for patients with acute myeloblastic leukemia in relapse after autologous blood stem cell transplantation.
    de la Rubia J; Sanz GF; Martín G; Sempere A; Picón I; Carral A; Larrea L; Martínez J; Soler MA; Bonanad S; López F; Jarque I; Sanz MA
    Bone Marrow Transplant; 1996 Dec; 18(6):1167-73. PubMed ID: 8971390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.